SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.88-1.2%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (24508)8/14/1998 4:45:00 PM
From: jayhawk969  Read Replies (1) of 32384
 
Thread,

The earnings release is disappointing but not totally unexpected. It obviously had a great deal to do with the late afternoon selloff.

The current price of the stock has negative implications for Ligand in at least two ways:

1. It will be difficult to do an early conversion on LGNDW at such low prices(why would anyone want to go from an investment that has a maximum risk in it of aprox. 3.5 to 3.5 plus the exercise price?).

2. Further obligations such as Lilly milestone payments and Ontak payments for Ontak approval are anticipated to be in stock. If stock is issued at this price it creates severe dilution. The alternative of cash is nt necessarily a good one either.

The pressure is on for this company and its leaders to perform to positively impact the stock price.

J.D.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext